WallStreetZenWallStreetZen

NASDAQ: PETQ
Petiq Inc Stock

$16.60+0.09 (+0.55%)
Updated Apr 23, 2024
PETQ Price
$16.60
Fair Value Price
N/A
Market Cap
$488.56M
52 Week Low
$11.26
52 Week High
$22.98
P/E
237.14x
P/B
2.21x
P/S
0.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.10B
Earnings
$2.13M
Gross Margin
22.9%
Operating Margin
3.31%
Profit Margin
0.2%
Debt to Equity
2.92
Operating Cash Flow
$62M
Beta
1.33
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PETQ Overview

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PETQ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PETQ is poor value based on its earnings relative to its share price (237.14x), compared to the US market average (41.92x)
P/E vs Market Valuation
PETQ is poor value based on its earnings relative to its share price (237.14x), compared to the US Drug Manufacturers - Specialty & Generic industry average (46.85x)
P/E vs Industry Valuation
PETQ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more PETQ due diligence checks available for Premium users.

Be the first to know about important PETQ news, forecast changes, insider trades & much more!

PETQ News

Valuation

PETQ fair value

Fair Value of PETQ stock based on Discounted Cash Flow (DCF)
Price
$16.60
Fair Value
$18.96
Undervalued by
12.45%

PETQ price to earnings (PE)

For valuing profitable companies with steady earnings
Company
237.14x
Industry
46.85x
Market
41.92x
PETQ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PETQ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

PETQ price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
2.07x
PETQ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PETQ's financial health

Profit margin

Revenue
$219.9M
Net Income
-$17.5M
Profit Margin
-8%
PETQ's Earnings (EBIT) of $36.51M... subscribe to Premium to read more.
Interest Coverage Financials
PETQ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$868.2M
Liabilities
$645.2M
Debt to equity
2.92
PETQ's short-term assets ($430.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PETQ's long-term liabilities ($455.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PETQ's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PETQ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.8M
Investing
-$2.9M
Financing
-$2.4M
PETQ's operating cash flow ($61.89M)... subscribe to Premium to read more.
Debt Coverage Financials

PETQ vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PETQ$488.56M+0.55%237.14x2.21x
PAHC$551.25M+4.29%36.78x2.04x
ORGO$393.25M+0.34%74.50x1.41x
ESPR$386.76M+9.42%-1.03x-0.85x
HROW$364.94M-2.64%-13.76x5.16x

Petiq Stock FAQ

What is Petiq's quote symbol?

(NASDAQ: PETQ) Petiq trades on the NASDAQ under the ticker symbol PETQ. Petiq stock quotes can also be displayed as NASDAQ: PETQ.

If you're new to stock investing, here's how to buy Petiq stock.

What is the 52 week high and low for Petiq (NASDAQ: PETQ)?

(NASDAQ: PETQ) Petiq's 52-week high was $22.98, and its 52-week low was $11.26. It is currently -27.76% from its 52-week high and 47.42% from its 52-week low.

How much is Petiq stock worth today?

(NASDAQ: PETQ) Petiq currently has 29,431,318 outstanding shares. With Petiq stock trading at $16.60 per share, the total value of Petiq stock (market capitalization) is $488.56M.

Petiq stock was originally listed at a price of $23.32 in Jul 21, 2017. If you had invested in Petiq stock at $23.32, your return over the last 6 years would have been -28.82%, for an annualized return of -5.51% (not including any dividends or dividend reinvestments).

How much is Petiq's stock price per share?

(NASDAQ: PETQ) Petiq stock price per share is $16.60 today (as of Apr 23, 2024).

What is Petiq's Market Cap?

(NASDAQ: PETQ) Petiq's market cap is $488.56M, as of Apr 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Petiq's market cap is calculated by multiplying PETQ's current stock price of $16.60 by PETQ's total outstanding shares of 29,431,318.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.